Meta Launches Ray-Ban Prescription Smart Glasses
Analysis based on 6 articles · First reported Mar 31, 2026 · Last updated Mar 31, 2026
The launch of new prescription smart glasses by Meta Platforms is expected to positively impact its stock price and market share in the smart eyewear segment. This move also highlights the growing competition in the AI-powered gadget market, with rivals like Snap Inc. and Alphabet Inc. also making advancements.
Meta Platforms has launched two new EssilorLuxottica — Ray-Ban prescription smart glasses, the EssilorLuxottica — Ray-Ban Meta Blayzer Optics and EssilorLuxottica — Ray-Ban Meta Scriber Optics, available for pre-order in the U.S. starting at $499. These new models, developed in partnership with EssilorLuxottica, expand Meta Platforms' successful line of AI-powered gadgets, addressing the large market of prescription eyewear users. The company plans to invest hundreds of billions of dollars in 'personal superintelligence' and AI development. This launch follows a delay in the global rollout of Meta Platforms' previous Meta EssilorLuxottica — Ray-Ban Display glasses due to supply shortages and strong demand. The smart glasses market is growing, with Meta Platforms holding a significant share, while competitors like Snap Inc. and Alphabet Inc. are also developing their own AI glasses.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard